Evidence-based practices for substance use disorders
- PMID: 14711132
- PMCID: PMC3678283
- DOI: 10.1016/s0193-953x(03)00073-x
Evidence-based practices for substance use disorders
Abstract
There are inherent complexities in evaluating EBPs for substance use disorders: the heterogeneity of the disorder itself, the variability in people who suffer from them, the range of settings in which services are provided, and multiple lines of research development. This article outlined four models for evaluating the evidence for interventions for substance use disorders, and presented brief descriptions of pharmacological, behavioral/psychosocial, and treatment services that have a clearly defined intervention (chemical agent or manual-guided therapy) and a documented record of objective evaluation. Although substantial work is underway to evaluate effectiveness in the real world, clinicians and individuals with substance use disorders and their families should be cognizant of the burgeoning array of effective treatment alternatives that are available.
Similar articles
-
Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.J Psychiatr Pract. 2005 Sep;11(5):315-39. doi: 10.1097/00131746-200509000-00005. J Psychiatr Pract. 2005. PMID: 16184072 Free PMC article. Review.
-
Challenges in implementing evidence-based treatment practices for co-occurring disorders in the criminal justice system.Behav Sci Law. 2004;22(4):431-48. doi: 10.1002/bsl.598. Behav Sci Law. 2004. PMID: 15282833
-
Psychosocial interventions for benzodiazepine harmful use, abuse or dependence.Cochrane Database Syst Rev. 2015;2015(5):CD009652. doi: 10.1002/14651858.CD009652.pub2. Cochrane Database Syst Rev. 2015. PMID: 26106751 Free PMC article. Review.
-
Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial.Addict Behav. 2009 Oct;34(10):859-66. doi: 10.1016/j.addbeh.2009.03.007. Epub 2009 Mar 12. Addict Behav. 2009. PMID: 19362429
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
Psychosocial treatment options for adolescents and young adults with alcohol use disorder: systematic review and meta-analysis.Front Public Health. 2024 Jul 23;12:1371497. doi: 10.3389/fpubh.2024.1371497. eCollection 2024. Front Public Health. 2024. PMID: 39114525 Free PMC article.
-
An Evaluation of Cognitive Behavioral Therapy for Substance Use Disorder: A Systematic Review and Application of the Society of Clinical Psychology Criteria for Empirically Supported Treatments.Clin Psychol (New York). 2023 Jun;30(2):129-142. doi: 10.1037/cps0000131. Epub 2023 Feb 27. Clin Psychol (New York). 2023. PMID: 37840853 Free PMC article.
-
Dissemination of Contingency Management for the Treatment of Opioid Use Disorder.Perspect Behav Sci. 2022 Feb 10;46(1):35-49. doi: 10.1007/s40614-022-00328-z. eCollection 2023 Mar. Perspect Behav Sci. 2022. PMID: 37006603 Free PMC article.
-
Substance use, current criminal justice involvement, and lifetime suicidal thoughts and behaviors history: The moderating role of thwarted belonging.Suicide Life Threat Behav. 2021 Apr;51(2):237-246. doi: 10.1111/sltb.12699. Suicide Life Threat Behav. 2021. PMID: 33876498 Free PMC article.
-
The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms.Epidemiol Rev. 2020 Jan 31;42(1):154-166. doi: 10.1093/epirev/mxaa011. Epidemiol Rev. 2020. PMID: 33511987 Free PMC article.
References
-
- Sobell LC, Toneatto T, Sobell Me. Behavioral assessment and treatment planning for alcohol, tobacco, and other drug problems: current status with an emphasis on clinical applications. Behavior Therapy. 1994;25:533–80.
-
- McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness. Implications for treatment, insurance, and outcomes evaluation. JAMA. 2001;284:1689–95. - PubMed
-
- McLellan AT, McKay JR. The treatment of addiction: what can research offer In? practice. In: Lamb S, Greenlick M, McCarty D, editors. Bridging the gap between practice and research: forging partnerships with community based drug and alcohol treatment. National Academy Press; Washington (DC): 1998. - PubMed
-
- O’Brien CP. A range of research-based pharmacotherapies for addiction. Science. 1997;278:66–70. - PubMed
-
- Rounsaville BJ, Kosten TR. Treatment for opioid dependence: quality and access. JAMA. 2000;283(10):1337–9. - PubMed